These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9509042)

  • 1. Management of spasticity.
    Ko CK; Ward AB
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):400-5. PubMed ID: 9509042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-spasticity medications.
    Al-Shahrani AM
    Saudi Med J; 2003 Jan; 24(1):19-22. PubMed ID: 12590267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for spasticity after stroke.
    Dobkin BH
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12530439
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European consensus statement on the use of botulinum toxin type A in the management of adult spasticity.
    Ward AB; Wissel J; Molteni F; Yakovleff A; Gedin S; Aguilar M; Kanovsky P; Zegers de Beyl D
    Acta Neurol Belg; 2003 Mar; 103(1):39. PubMed ID: 12704982
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin for spasticity after stroke.
    Buitrago MM; Koolwijk I
    N Engl J Med; 2003 Jan; 348(3):258-9; author reply 258-9. PubMed ID: 12530438
    [No Abstract]   [Full Text] [Related]  

  • 9. [New therapies for spastic movement disorders].
    Benecke R; Patejdl R
    MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
    [No Abstract]   [Full Text] [Related]  

  • 10. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
    Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical treatment (non surgical) of spasticity in cerebral palsy].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):1-6. PubMed ID: 11988886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ever more indications for botulinum toxin. A toxin for many cases (interview by Dr. Judith Neumaier)].
    Hecht M
    MMW Fortschr Med; 2010 Mar; 152(9):14-5. PubMed ID: 20384088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods for diminishing spasticity in an attempt to facilitate complex rehabilitation of paraplegics].
    Makowski J; Kiwerski J; Chromiec E; Chrostowska T
    Chir Narzadow Ruchu Ortop Pol; 1972; 37(5):571-6. PubMed ID: 4641290
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for the treatment of child spasticity using botulinum toxin].
    Pascual-Pascual SI; Herrera-Galante A; Póo P; García-Aymerich V; Aguilar-Barberà M; Bori-Fortuny I; García-Ruiz PJ; Garreta-Figuera R; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Vivancos-Matellano F;
    Rev Neurol; 2007 Mar 1-15; 44(5):303-9. PubMed ID: 17342682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 20. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.